- Conditions
- Overactive Bladder Syndrome, Neuropathic Bladder
- Interventions
- Oxybutynin Transdermal Patch, Oral Oxybutynin
- Drug
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 4 Years to 8 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 1
- States / cities
- Sacramento, California
Source: ClinicalTrials.gov public record
Updated Jan 28, 2026 · Synced May 22, 2026, 12:50 AM EDT